Mayo Clinic researchers present advances in immunotherapy, biomarkers and tumor biology at AACR 2026
Mayo Clinic Comprehensive Cancer Center scientists, physicians and trainees will present nearly 60 studies on emerging cancer therapies, diagnostics and prevention strategies at the 2026 American ...
Detailed price information for Kymera Therapeutics Inc (KYMR-Q) from The Globe and Mail including charting and trades.
Twenty years after the approval of the first vaccines against human papillomavirus (HPV), studies continue to find new ...
SurvivorNet on MSN
'Mo-Rez,' a developing ovarian cancer drug, outperforms current standards with 60% response rates, offering first real hope in years
Early data show the cancer drug mocertatug rezetecan (Mo‑Rez) delivering response rates above 60% in patients with ovarian ...
Kellan Hilson and Rupi Danlag, both battling cancer, were part of the annual Gulf Coast event that raised more than $729,000.
The incidence of early-onset oral cavity squamous cell carcinoma on the tongue, the most common subsite, increased over time.
The advent of mRNA vaccines against SARS-CoV-2 in 2020 changed the course of the COVID-19 pandemic. Now, the Nobel ...
Explore surgical options for metastatic bladder cancer, including radical cystectomy and metastasectomy. Learn how surgery ...
Researchers from The University of Texas MD Anderson Cancer Center will present breakthrough studies at the American Association for Cancer Research (AACR) Annual Meeting 2026.
Krista Powers used 3-D tattooing to mirror the look of areolas on her breasts ...
EatingWell on MSN
This common habit may reduce oral cancer risk, according to experts
Oral cancer is on the rise. Here’s the best way to protect yourself.
Akamis Bio, a clinical-stage oncology company working to advance the standard of care in colorectal cancer, today announced early data from the on-going Phase 1b FORTRESS study of NG-350A, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results